{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T13:35:47Z","timestamp":1787578547218,"version":"build-2736575974"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T00:00:00Z","timestamp":1781568000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T00:00:00Z","timestamp":1787529600000},"content-version":"vor","delay-in-days":69,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["22304027"],"award-info":[{"award-number":["22304027"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003392","name":"Natural Science Foundation of Fujian Province","doi-asserted-by":"publisher","award":["2025J01709"],"award-info":[{"award-number":["2025J01709"]}],"id":[{"id":"10.13039\/501100003392","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Joint Funds for the Innovation of Science and Technology, Fujian Province","award":["2024Y9109"],"award-info":[{"award-number":["2024Y9109"]}]},{"name":"Joint Funds for the Innovation of Science and Technology, Fujian Province","award":["2024Y9103"],"award-info":[{"award-number":["2024Y9103"]}]},{"name":"Joint Funds for the Innovation of Science and Technology, Fujian Province","award":["2024Y9107"],"award-info":[{"award-number":["2024Y9107"]}]},{"name":"Startup Fund for Scientific Research, Fujian Medical University","award":["XRCZX2021015"],"award-info":[{"award-number":["XRCZX2021015"]}]},{"name":"Scientific Research Foundation of State Key Laboratory of Vaccines for Infectious Diseases, and Xiang An Biomedicine Laboratory","award":["2023XAKJ0101018"],"award-info":[{"award-number":["2023XAKJ0101018"]}]},{"name":"Hunan Innovative Provincial Construction Projects","award":["2023JJ70032"],"award-info":[{"award-number":["2023JJ70032"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"DOI":"10.1186\/s12951-026-04681-y","type":"journal-article","created":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T01:14:28Z","timestamp":1781572468000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Dual-targeting VEGF and TNF-\u03b1 with bispecific antibody eyedrops for synergistic treatment of uveitis"],"prefix":"10.1186","volume":"24","author":[{"given":"Jie","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinqi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruochu","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenchao","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiqing","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panxiang","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sisi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Penfeng","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yihua","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biting","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nanwen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juhua","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaole","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,16]]},"reference":[{"issue":"5","key":"4681_CR1","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1001\/jama.2025.4358","volume":"334","author":"P Maghsoudlou","year":"2025","unstructured":"Maghsoudlou P, Epps SJ, Guly CM, et al. Uveitis in adults. JAMA. 2025;334(5):419\u201334. https:\/\/doi.org\/10.1001\/jama.2025.4358.","journal-title":"JAMA"},{"issue":"3","key":"4681_CR2","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/j.semarthrit.2019.06.004","volume":"49","author":"JT Rosenbaum","year":"2019","unstructured":"Rosenbaum JT, Bodaghi B, Couto C, et al. New observations and emerging ideas in diagnosis and management of non-infectious uveitis: a review[J]. Semin Arthritis Rheum. 2019;49(3):438\u201345. https:\/\/doi.org\/10.1016\/j.semarthrit.2019.06.004.","journal-title":"Semin Arthritis Rheum"},{"key":"4681_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2022.121836","volume":"622","author":"Y Zhu","year":"2022","unstructured":"Zhu Y, Zhou J, Hu Y, et al. Single subcutaneous injection of the minocycline nanocomposite-loaded thermosensitive hydrogel for the effective attenuation of experimental autoimmune uveitis. Int J Pharm. 2022;622:121836. https:\/\/doi.org\/10.1016\/j.ijpharm.2022.121836.","journal-title":"Int J Pharm"},{"issue":"9","key":"4681_CR4","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1016\/j.ophtha.2024.02.019","volume":"131","author":"JR Smith","year":"2024","unstructured":"Smith JR, Thorne JE, Flaxel CJ, et al. Treatment of noninfectious uveitic macular edema with periocular and intraocular corticosteroid therapies. Ophthalmology. 2024;131(9):1107\u201320. https:\/\/doi.org\/10.1016\/j.ophtha.2024.02.019.","journal-title":"Ophthalmology"},{"key":"4681_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2023.114869","volume":"198","author":"S Teabagy","year":"2023","unstructured":"Teabagy S, Wood E, Bilsbury E, et al. Ocular immunosuppressive microenvironment and novel drug delivery for control of uveitis. Adv Drug Deliv Rev. 2023;198:114869. https:\/\/doi.org\/10.1016\/j.addr.2023.114869.","journal-title":"Adv Drug Deliv Rev"},{"key":"4681_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.exer.2025.110456","volume":"257","author":"A Ambekar","year":"2025","unstructured":"Ambekar A, Sahoo J, Singh K. Breaking barriers in ocular drug delivery for uveitis: advanced drug delivery systems, challenges and future prospects[J]. Exp Eye Res. 2025;257:110456. https:\/\/doi.org\/10.1016\/j.exer.2025.110456.","journal-title":"Exp Eye Res"},{"issue":"10326","key":"4681_CR7","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1016\/S0140-6736(22)00010-1","volume":"399","author":"JS Heier","year":"2022","unstructured":"Heier JS, Khanani AM, Quezada Ruiz C, et al. Efficacy, durability, and safety of intravitreal faricimab up to every 16 weeks for neovascular age-related macular degeneration (tenaya and lucerne): two randomised, double-masked, phase 3, non-inferiority trials. Lancet. 2022;399(10326):729\u201340. https:\/\/doi.org\/10.1016\/S0140-6736(22)00010-1.","journal-title":"Lancet"},{"issue":"1","key":"4681_CR8","doi-asserted-by":"publisher","DOI":"10.1186\/s12348-020-00202-6","volume":"10","author":"F Nicolela Susanna","year":"2020","unstructured":"Nicolela Susanna F, Pavesio C. A review of ocular adverse events of biological anti-tnf drugs. J Ophthalmic Inflamm Infect. 2020;10(1):11. https:\/\/doi.org\/10.1186\/s12348-020-00202-6.","journal-title":"J Ophthalmic Inflamm Infect"},{"key":"4681_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.mtbio.2025.102051","volume":"33","author":"Y Geng","year":"2025","unstructured":"Geng Y, Zhang J, Song S, et al. Inorganic nanomaterials as promising therapeutic agents for ocular neovascularization: progress and perspectives. Mater Today Bio. 2025;33:102051. https:\/\/doi.org\/10.1016\/j.mtbio.2025.102051.","journal-title":"Mater Today Bio"},{"key":"4681_CR10","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.jconrel.2023.08.041","volume":"362","author":"M Shafiq","year":"2023","unstructured":"Shafiq M, Rafique M, Cui Y, et al. An insight on ophthalmic drug delivery systems: focus on polymeric biomaterials-based carriers. J Control Release. 2023;362:446\u201367. https:\/\/doi.org\/10.1016\/j.jconrel.2023.08.041.","journal-title":"J Control Release"},{"key":"4681_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2023.114770","volume":"196","author":"H Han","year":"2023","unstructured":"Han H, Li S, Xu M, et al. Polymer- and lipid-based nanocarriers for ocular drug delivery: current status and future perspectives. Adv Drug Deliv Rev. 2023;196:114770. https:\/\/doi.org\/10.1016\/j.addr.2023.114770.","journal-title":"Adv Drug Deliv Rev"},{"issue":"32","key":"4681_CR12","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202403399","volume":"11","author":"Y Wu","year":"2024","unstructured":"Wu Y, Li X, Fu X, et al. Innovative nanotechnology in drug delivery systems for advanced treatment of posterior segment ocular diseases. Adv Sci. 2024;11(32):e2403399. https:\/\/doi.org\/10.1002\/advs.202403399.","journal-title":"Adv Sci"},{"issue":"18","key":"4681_CR13","doi-asserted-by":"publisher","first-page":"22850","DOI":"10.1021\/acsami.4c00564","volume":"16","author":"D Zhang","year":"2024","unstructured":"Zhang D, He J, Hua SY, et al. Reactive oxygen species-responsive dual anti-inflammatory and antioxidative nanoparticles for anterior uveitis. ACS Appl Mater Interfaces. 2024;16(18):22850\u201364. https:\/\/doi.org\/10.1021\/acsami.4c00564.","journal-title":"ACS Appl Mater Interfaces"},{"issue":"24","key":"4681_CR14","doi-asserted-by":"publisher","first-page":"25377","DOI":"10.1021\/acsnano.3c08869","volume":"17","author":"X Liu","year":"2023","unstructured":"Liu X, Chen Z, Bai J, et al. Multifunctional hydrogel eye drops for synergistic treatment of ocular inflammatory disease. ACS Nano. 2023;17(24):25377\u201390. https:\/\/doi.org\/10.1021\/acsnano.3c08869.","journal-title":"ACS Nano"},{"key":"4681_CR15","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2026.1717056","volume":"13","author":"J Han","year":"2026","unstructured":"Han J, Harper J, Copland DA, et al. The immunopathogenesis of uveitis. Front Med. 2026;13:1717056. https:\/\/doi.org\/10.3389\/fmed.2026.1717056.","journal-title":"Front Med"},{"issue":"1","key":"4681_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-56810-0","volume":"16","author":"H Song","year":"2025","unstructured":"Song H, Li Q, Gui X, et al. Endothelial protein c receptor promotes retinal neovascularization through heme catabolism. Nat Commun. 2025;16(1):1603. https:\/\/doi.org\/10.1038\/s41467-025-56810-0.","journal-title":"Nat Commun"},{"issue":"3","key":"4681_CR17","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.survophthal.2024.12.004","volume":"70","author":"A Servillo","year":"2025","unstructured":"Servillo A, Scandale P, Oldoni G, et al. Inflammatory choroidal neovascularization: an evidence-based update. Surv Ophthalmol. 2025;70(3):451\u201366. https:\/\/doi.org\/10.1016\/j.survophthal.2024.12.004.","journal-title":"Surv Ophthalmol"},{"issue":"5","key":"4681_CR18","doi-asserted-by":"publisher","first-page":"698","DOI":"10.4103\/IJO.IJO_2975_25","volume":"74","author":"A Kawali","year":"2026","unstructured":"Kawali A, Mishra SB, Mahendradas P, et al. Anti-vascular endothelial growth factor therapy in uveitis: bridging inflammation and vascular pathology. Indian J Ophthalmol. 2026;74(5):698\u2013706. https:\/\/doi.org\/10.4103\/IJO.IJO_2975_25.","journal-title":"Indian J Ophthalmol"},{"key":"4681_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2023.111240","volume":"126","author":"N Zhang","year":"2024","unstructured":"Zhang N, Zheng N, Luo D, et al. A novel single domain bispecific antibody targeting vegf and tnf-\u03b1 ameliorates rheumatoid arthritis. Int Immunopharmacol. 2024;126:111240. https:\/\/doi.org\/10.1016\/j.intimp.2023.111240.","journal-title":"Int Immunopharmacol"},{"key":"4681_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.112309","volume":"136","author":"M Sharma","year":"2024","unstructured":"Sharma M, Pal P, Gupta SK. Microglial mediators in autoimmune uveitis: bridging neuroprotection and neurotoxicity. Int Immunopharmacol. 2024;136:112309. https:\/\/doi.org\/10.1016\/j.intimp.2024.112309.","journal-title":"Int Immunopharmacol"},{"key":"4681_CR21","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26114992","author":"A Callan","year":"2025","unstructured":"Callan A, Heckman J, Tah G, et al. VEGF in diabetic retinopathy and age-related macular degeneration. Int J Mol Sci. 2025. https:\/\/doi.org\/10.3390\/ijms26114992.","journal-title":"Int J Mol Sci"},{"key":"4681_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2025.156922","volume":"190","author":"CT Ng","year":"2025","unstructured":"Ng CT, Fong LY, Tan JJ, et al. Endothelial barrier disruptive effect of ifn-\u01b4 and tnf-\u03b1: synergism of pro-inflammatory cytokines. Cytokine. 2025;190:156922. https:\/\/doi.org\/10.1016\/j.cyto.2025.156922.","journal-title":"Cytokine"},{"issue":"1","key":"4681_CR23","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-021-02203-1","volume":"18","author":"K Takahashi","year":"2021","unstructured":"Takahashi K, Nakamura S, Otsu W, et al. Progranulin deficiency in iba-1(+) myeloid cells exacerbates choroidal neovascularization by perturbation of lysosomal function and abnormal inflammation. J Neuroinflammation. 2021;18(1):164. https:\/\/doi.org\/10.1186\/s12974-021-02203-1.","journal-title":"J Neuroinflammation"},{"issue":"1","key":"4681_CR24","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-017-0915-5","volume":"14","author":"DA Lipski","year":"2017","unstructured":"Lipski DA, Dewispelaere R, Foucart V, et al. MHC class II expression and potential antigen-presenting cells in the retina during experimental autoimmune uveitis. J Neuroinflammation. 2017;14(1):136. https:\/\/doi.org\/10.1186\/s12974-017-0915-5.","journal-title":"J Neuroinflammation"},{"issue":"1","key":"4681_CR25","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1080\/19768354.2024.2304557","volume":"28","author":"S Hong","year":"2024","unstructured":"Hong S, Jung K, Ahn M, et al. Eugenol ameliorates uveitis in mice with experimental autoimmune encephalomyelitis through the suppression of key inflammatory genes. Animal Cells Syst. 2024;28(1):37\u201344. https:\/\/doi.org\/10.1080\/19768354.2024.2304557.","journal-title":"Animal Cells Syst"},{"issue":"12","key":"4681_CR26","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.70021","volume":"5","author":"Y Wang","year":"2024","unstructured":"Wang Y, Gao S, Cao F, et al. Ocular immune-related diseases: molecular mechanisms and therapy. MedComm. 2024;5(12):e70021. https:\/\/doi.org\/10.1002\/mco2.70021.","journal-title":"MedComm"},{"issue":"1","key":"4681_CR27","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-023-01992-2","volume":"21","author":"S Li","year":"2023","unstructured":"Li S, Chen L, Fu Y. Nanotechnology-based ocular drug delivery systems: recent advances and future prospects. J Nanobiotechnol. 2023;21(1):232. https:\/\/doi.org\/10.1186\/s12951-023-01992-2.","journal-title":"J Nanobiotechnol"},{"key":"4681_CR28","doi-asserted-by":"publisher","DOI":"10.3390\/ijms252312910","author":"DV Chistyakov","year":"2024","unstructured":"Chistyakov DV, Tiulina VV, Gancharova OS, et al. Targeting oxidative stress and inflammation in the eye: insights from a new model of experimental autoimmune uveitis. Int J Mol Sci. 2024. https:\/\/doi.org\/10.3390\/ijms252312910.","journal-title":"Int J Mol Sci"},{"key":"4681_CR29","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.intimp.2017.05.021","volume":"49","author":"S-B Lee","year":"2017","unstructured":"Lee S-B, Lee WS, Shin J-S, et al. Xanthotoxin suppresses LPS-induced expression of iNOS, COX-2, TNF-\u03b1, and IL-6 via AP-1, NF-\u03baB, and JAK-STAT inactivation in RAW 264.7 macrophages. Int Immunopharmacol. 2017;49:21\u20139. https:\/\/doi.org\/10.1016\/j.intimp.2017.05.021.","journal-title":"Int Immunopharmacol"},{"key":"4681_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2024.122563","volume":"345","author":"M Malekan","year":"2024","unstructured":"Malekan M, Haass NK, Rokni GR, et al. VEGF\/VEGFR axis and its signaling in melanoma: current knowledge toward therapeutic targeting agents and future perspectives. Life Sci. 2024;345:122563. https:\/\/doi.org\/10.1016\/j.lfs.2024.122563.","journal-title":"Life Sci"},{"key":"4681_CR31","doi-asserted-by":"publisher","DOI":"10.3390\/cells10020396","author":"M Eskandarpour","year":"2021","unstructured":"Eskandarpour M, Nunn MA, Weston-Davies W, et al. Immune-mediated retinal vasculitis in posterior uveitis and experimental models: the leukotriene (LT)B4-VEGF axis. Cells. 2021. https:\/\/doi.org\/10.3390\/cells10020396.","journal-title":"Cells"},{"key":"4681_CR32","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2025.1729606","volume":"16","author":"C Wu","year":"2025","unstructured":"Wu C, Shen Y, Xu C, et al. Synergistic therapy for diabetic retinopathy via dual blockade of VEGF-A and TNF-\u03b1 with a bispecific nanobody. Front Pharmacol. 2025;16:1729606. https:\/\/doi.org\/10.3389\/fphar.2025.1729606.","journal-title":"Front Pharmacol"},{"issue":"12","key":"4681_CR33","doi-asserted-by":"publisher","first-page":"94907904","DOI":"10.26599\/NR.2025.94907904","volume":"18","author":"J Zhou","year":"2025","unstructured":"Zhou J, Lin S, Zhou B, et al. Dithiolane-based antibody eyedrops for noninvasive treatment of corneal neovascularization[J]. Nano Res. 2025;18(12):94907904. https:\/\/doi.org\/10.26599\/NR.2025.94907904.","journal-title":"Nano Res"},{"key":"4681_CR34","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.preteyeres.2014.11.004","volume":"45","author":"M Karlstetter","year":"2015","unstructured":"Karlstetter M, Scholz R, Rutar M, et al. Retinal microglia: just bystander or target for therapy?[J]. Prog Retin Eye Res. 2015;45:30\u201357. https:\/\/doi.org\/10.1016\/j.preteyeres.2014.11.004.","journal-title":"Prog Retin Eye Res"},{"issue":"40","key":"4681_CR35","doi-asserted-by":"publisher","first-page":"35333","DOI":"10.1021\/acsnano.4c14313","volume":"19","author":"S Liu","year":"2025","unstructured":"Liu S, Wang D, Ye S, et al. Disulfide-appended siRNA nanoeyedrops: noninvasive gene therapy for targeting retinal angiogenesis. ACS Nano. 2025;19(40):35333\u201347. https:\/\/doi.org\/10.1021\/acsnano.4c14313.","journal-title":"ACS Nano"},{"key":"4681_CR36","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2024.1421959","volume":"11","author":"MS Baig","year":"2024","unstructured":"Baig MS, Karade SK, Ahmad A, et al. Lipid-based nanoparticles: innovations in ocular drug delivery. Front Mol Biosci. 2024;11:1421959. https:\/\/doi.org\/10.3389\/fmolb.2024.1421959.","journal-title":"Front Mol Biosci"},{"key":"4681_CR37","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.ajo.2023.06.021","volume":"254","author":"GN Papaliodis","year":"2023","unstructured":"Papaliodis GN, Rosner BA, Dreger KA, et al. Incidence of and risk factors for cataract in anterior uveitis. Am J Ophthalmol. 2023;254:221\u201332. https:\/\/doi.org\/10.1016\/j.ajo.2023.06.021.","journal-title":"Am J Ophthalmol"},{"issue":"W1","key":"4681_CR38","doi-asserted-by":"publisher","first-page":"W306","DOI":"10.1093\/nar\/gkaf379","volume":"53","author":"X Zhang","year":"2025","unstructured":"Zhang X, Jiang L, Weng G, et al. HawkDock version 2: an updated web server to predict and analyze the structures of protein-protein complexes. Nucleic Acids Res. 2025;53(W1):W306\u201315. https:\/\/doi.org\/10.1093\/nar\/gkaf379.","journal-title":"Nucleic Acids Res"},{"key":"4681_CR39","doi-asserted-by":"publisher","unstructured":"Agarwal RK, Silver PB, Caspi RR. Rodent models of experimental autoimmune uveitis[J]. Methods Mol Biol (Clifton, N.J.), 2012; 900: 443\u2013469. https:\/\/doi.org\/10.1007\/978-1-60761-720-4_22.","DOI":"10.1007\/978-1-60761-720-4_22"}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12951-026-04681-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-026-04681-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-026-04681-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T13:14:16Z","timestamp":1787577256000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12951-026-04681-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,16]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4681"],"URL":"https:\/\/doi.org\/10.1186\/s12951-026-04681-y","relation":{},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,16]]},"assertion":[{"value":"20 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interest","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"801"}}